Literature DB >> 36267792

Circ_0001658 regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and affects the progress of papillary thyroid carcinoma.

Xiaoyu Liu1, Congren Wang1, Zijian Su1, Shaoyang Cai1, Qunxiong Pan1, Xiangjin Chen2.   

Abstract

Background: Circular RNAs (circRNAs) are a newly described class of non-coding RNAs that play essential roles in regulating gene expression. However, to date, few studies have examined the roles of circRNAs in papillary thyroid carcinoma (PTC). In this study, we analyzed the expression of circ_0001658 in PTC as well as its functions and associated mechanisms of action in PTC cells.
Methods: Real-time quantitative polymerase chain reaction was used to determine the expression of circ_0001658, miR-671-5p, and integrin subunit alpha 2 (ITGA2), and western blotting was performed to determine the levels of ITGA2 and phosphatidylinositide 3-kinase/protein kinase B pathway-related proteins in PTC cell lines. Cell Counting Kit-8 and Transwell analyses were conducted to examine the effects of circ_0001658 on PTC cell function following the knockdown of circ_0001658 expression. In addition, the targeting of circ_0001658 and ITGA2 by miR-671-5p was verified using dual-luciferase reporter assays.
Results: We demonstrated that circ_0001658 and ITGA2 were significantly up-regulated in PTC tissues and cell lines. Knockdown of circ_0001658 inhibited the growth and metastatic potential of PTC cells. MiR-671-5p targeted both circ_0001658 and ITGA2. Mechanistically, circ_0001658 promoted PTC progression by sponging miR-671-5p, up-regulating ITGA2 expression, and activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. In summary, circ_0001658 is a carcinogenesis-associated circRNA that regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and plays a role in promoting the progression of PTC. Conclusions: Our findings provide a theoretical basis for further molecular biological studies on the treatment of PTC. 2022 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Circ_0001658; PI3K/AKT; integrin subunit alpha 2 (ITGA2); miR-671-5p; papillary thyroid carcinoma (PTC)

Year:  2022        PMID: 36267792      PMCID: PMC9577784          DOI: 10.21037/atm-22-3650

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  40 in total

1.  microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.

Authors:  Duo-Ping Wang; Xiao-Zhun Tang; Quan-Kun Liang; Xian-Jie Zeng; Jian-Bo Yang; Jian Xu
Journal:  J Cell Physiol       Date:  2019-09-29       Impact factor: 6.384

Review 2.  Endogenous microRNA sponges: evidence and controversy.

Authors:  Daniel W Thomson; Marcel E Dinger
Journal:  Nat Rev Genet       Date:  2016-04-04       Impact factor: 53.242

3.  MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.

Authors:  Y-C Wu; S-Y Li; Y-F Jia
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-10       Impact factor: 3.507

4.  miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.

Authors:  Chuanshan Zang; Jian Sun; Wenyi Liu; Chunqin Chu; Liwei Jiang; Ruifeng Ge
Journal:  Hum Cell       Date:  2019-06-03       Impact factor: 4.174

5.  Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?

Authors:  Victoria Harries; Laura Y Wang; Marlena McGill; Bin Xu; R Michael Tuttle; Richard J Wong; Ashok R Shaha; Jatin P Shah; Ronald Ghossein; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2019-09-09       Impact factor: 3.982

6.  CircRNA in cancer: Fundamental mechanism and clinical potential.

Authors:  Liang Chen; Ge Shan
Journal:  Cancer Lett       Date:  2021-02-18       Impact factor: 8.679

Review 7.  Targeting PI3K/Akt/mTOR Signaling in Cancer.

Authors:  Camillo Porta; Chiara Paglino; Alessandra Mosca
Journal:  Front Oncol       Date:  2014-04-14       Impact factor: 6.244

8.  Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.

Authors:  Linwen Zeng; Shaofeng Yuan; Pengfei Zhou; Jianming Gong; Xiangdong Kong; Ming Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis.

Authors:  Valery Adorno-Cruz; Andrew D Hoffmann; Xia Liu; Nurmaa K Dashzeveg; Rokana Taftaf; Brian Wray; Ruth A Keri; Huiping Liu
Journal:  Genes Dis       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.